Bleeding Patterns During Prophylaxis with a Full-Length Pegylated Recombinant Factor VIII (Bax 855) with Extended Half-Life in Hemophilia A

被引：0
|
作者：
Konkle, B. A. [1 ,2 ]
Stasyshn, O. [3 ]
Wynn, T. T. [4 ]
Manco-Johnson, M. J. [5 ]
Gruppo, R. [6 ]
Chowdary, P. [7 ,8 ]
Komrska, V. [9 ]
Griskevicius, L. [10 ]
Eyster, M. E. [11 ]
Chojnowski, K. [12 ]
Engl, W. [13 ]
Patrone, L. [14 ]
Abbuehl, B. [13 ]
机构：
[1] Bloodworks Northwest, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Ukraine Acad Med Sci, Lvov, Ukraine
[4] Univ Florida, Coll Med, Gainesville, FL USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
[6] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[7] Royal Free Hosp, KD Haemophilia Ctr, Pond St, London NW3 2QG, England
[8] Royal Free Hosp, Thrombosis Unit, Pond St, London NW3 2QG, England
[9] Univ Hosp Motol, Prague, Czech Republic
[10] Vilnius Univ Hosp Santariskiu Klinikos, Vilnius, Lithuania
[11] Penn State Hershey Med Ctr, Hershey, PA USA
[12] Med Univ Lodz, Lodz, Poland
[13] Baxalta Innovat GmbH, Vienna, Austria
[14] Baxalta US Inc, Westlake Village, CA USA
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P128
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [1] Bleeding patterns evaluated during prophylaxis with a full-length pegylated recombinant factor VIII (bax 855) with extended half-life in hemophilia A
    Konkle, B.
    Stasyshn, O.
    Wynn, T.
    Manco-Johnson, M.
    Gruppo, R.
    Chowdary, P.
    Komrska, V
    Griskevicius, L.
    Eyster, M. E.
    Chojnowski, K.
    Engl, W.
    Patrone, L.
    Abbuehl, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 356 - 357
  • [2] Joint Bleeding Patterns in Patients Treated Prophylactically with an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855)
    Manco-Johnson, Marilyn J.
    Ma, Alice D.
    Klamroth, Robert
    Engl, Werner
    Griparic, Lorena
    Dyck-Jones, Jacqueline A.
    Abbuehl, Brigitt E.
    BLOOD, 2015, 126 (23)
  • [3] Characteristics of Patients without Bleeding in a Pivotal Trial of Extended Half-Life, Pegylated, Full-length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia A
    Ma, Alice D.
    Klamroth, Robert
    Manco-Johnson, Marilyn J.
    Engl, Werner
    Dyck-Jones, Jacqueline A.
    Abbuehl, Brigitt E.
    BLOOD, 2015, 126 (23)
  • [4] Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures
    Brand, Brigitte
    Gruppo, Ralph A.
    Wynn, Tung T.
    Griskevicius, Laimonas
    Fernandez, Maria Fernanda Lopez
    Dvorak, Thomas
    Patrone, Lisa
    Abbuehl, Brigitt E.
    BLOOD, 2015, 126 (23)
  • [5] Course of target joint bleeding with prophylaxis of a pegylated full-length recombinant factor VIII with extended half-life in patients with hemophilia A
    Abbuehl, Brigitt
    Engl, Werner
    Patrone, Lisa
    Prener, Anne
    HAEMOPHILIA, 2016, 22 : 48 - 48
  • [6] An Integrated Analysis of Long Term Safety of an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia a
    Chowdary, Pratima
    Konkle, Barbara
    Matsushita, Tadashi
    Engl, Werner
    Patrone, Lisa
    Abbuehl, Brigitt E.
    BLOOD, 2015, 126 (23)
  • [7] CHARACTERISTICS OF PATIENTS WITH AND WITHOUT BLEEDING IN A PIVOTAL TRIAL OF EXTENDED HALF-LIFE, PEGYLATED, FULL-LENGTH RECOMBINANT FACTOR VIII (BAX855) FOR THE PROPHYLACTIC TREATMENT OF HEMOPHILIA A
    Ma, Alice
    Klamroth, Robert
    Manco-Johnson, Marilyn
    Engl, Werner
    Dyck-Jones, Jacqueline
    Abbuehl, Brigitt
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E402 - E402
  • [8] Pharmacokinetics and preliminary immunogenicity of BAX 855, a PEGylated full-length recombinant factor VIII (PEG-rFVIII) with extended half-life
    Konkle, Barbara
    Stasyshyn, Oleksandra
    Gruppo, Ralph
    Ploder, Bettina
    Patrone, Lisa
    Abbuehl, Brigitt
    HAEMOPHILIA, 2014, 20 : 15 - 15
  • [9] Evaluation of long-term prophylaxis with a pegylated full-length recombinant factor VIII with extended half-life in patients with hemophilia A
    Abbuehl, Brigitt
    Engl, Werner
    Patrone, Lisa
    Prener, Anne
    HAEMOPHILIA, 2016, 22 : 108 - 108
  • [10] Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A
    Mullins, E. S.
    Stasyshyn, O.
    Alvarez-Roman, M. T.
    Osman, D.
    Liesner, R.
    Engl, W.
    Sharkhawy, M.
    Abbuehl, B. E.
    HAEMOPHILIA, 2017, 23 (02) : 238 - 246
12345